Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 363

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 363
---

an amendment (the “First IMTA Amendment”) to the Company’s Investment Management Trust Agreement (the “IMTA”),
dated October 5, 2021, with Continental Stock Transfer & Trust Company (“CST”), as trustee, and an amendment to the Company’s
Charter (the “First Charter Amendment”), to extend the business combination period up to three times for three months each
time (the “First Extension”).

In connection with the First Special Meeting, the
Sponsor agreed that if the First Charter Amendment and the First IMTA Amendment were approved at the First Special Meeting, the Sponsor,
or one or more of its affiliates, members or third-party designees (in such capacity, the “Lender”), would lend to the Company
up to $1,500,000 to be deposited into the Trust Account established in connection with the IPO. Accordingly, on December 20, 2022, the
Company issued an unsecured promissory note in the principal amount of $1,500,000 (the “Promissory Note”) to the Lender,
pursuant to which the Lender agreed to loan to the Company up to $1,500,000 in connection with the extension of the date by which the
Company has to consummate an initial Business Combination.

In connection with the approval of the Extension,
holders of 16,211,702 Public Shares exercised redemption rights. As a result, following the satisfaction of such redemptions, as of December
31, 2022, the Company had 2,173,298 shares of Class A common stock outstanding, of which (i) 1,288,298 were Public Shares, which were
entitled to receive a pro rata portion of the remaining funds in the Trust Account in connection with its initial Business Combination,
a liquidation or certain other events, and (ii) 885,000 were Private Placement Shares, which did not have redemption rights.

<div align='center'>F-32

PHOENIX BIOTECH ACQUISITION CORP.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2023</div>

On March 31, 2023, May 8, 2023 and June 30, 2023,
the Company deposited $100,000, $125,000 and $150,000 into the Trust Account in connection with the First Extension.

On July 7, 2023, the Company held a special